---
figid: PMC3411810__pone.0042598.g006
figlink: /pmc/articles/PMC3411810/figure/pone-0042598-g006/
number: F6
caption: (A) In cells with “wild-type” AKT signaling, the presence of BRAFV600E exerts
  a negative impact through mTORC2 on AKT phosphorylation and pathway activation.
  Suppression of AKT activity leads to a de-repression of AKT substrates PRAS40, FOXO
  and GSK3β due to the reduction of AKT-mediated phosphorylation. (B) In cells where
  AKT signaling is aberrantly activated (by PTEN loss, PI3K activation, or RTK amplification),
  the negative impact of BRAFV600E is countered by a dominant input upstream of AKT.
  Consequently, activated AKT phosphorylates substrates PRAS40, FOXO and GSK3β and
  suppresses their activity.
pmcid: PMC3411810
papertitle: BRAFV600E Negatively Regulates the AKT Pathway in Melanoma Cell Lines.
reftext: Brenden Chen, et al. PLoS One. 2012;7(8):e42598.
pmc_ranked_result_index: '64126'
pathway_score: 0.9370979
filename: pone.0042598.g006.jpg
figtitle: BRAFV600E Negatively Regulates the AKT Pathway in Melanoma Cell Lines
year: '2012'
organisms:
- Homo sapiens
ndex: 3bb232b3-def1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3411810__pone.0042598.g006.html
  '@type': Dataset
  description: (A) In cells with “wild-type” AKT signaling, the presence of BRAFV600E
    exerts a negative impact through mTORC2 on AKT phosphorylation and pathway activation.
    Suppression of AKT activity leads to a de-repression of AKT substrates PRAS40,
    FOXO and GSK3β due to the reduction of AKT-mediated phosphorylation. (B) In cells
    where AKT signaling is aberrantly activated (by PTEN loss, PI3K activation, or
    RTK amplification), the negative impact of BRAFV600E is countered by a dominant
    input upstream of AKT. Consequently, activated AKT phosphorylates substrates PRAS40,
    FOXO and GSK3β and suppresses their activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - PTEN
  - PIK3CG
  - AKT1S1
  - GSK3B
  - MAP2K2
  - PIK3CA
  - PIK3R3
  - RICTOR
  - MAP2K1
  - FOXO4
  - FOXO6
  - PIK3CD
  - FOXO1
  - FOXO3
  - PIK3R4
  - PIK3R6
  - RPTOR
  - AKT1
  - MAPK1
  - PIK3CB
  - AKT2
  - MLST8
  - PDK1
  - PIK3R5
  - AKT3
  - MAPK3
  - MAPKAP1
  - Cancer
genes:
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K/PTEN
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PRAS40
  symbol: PRAS40
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1S1
  entrez: '84335'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K/PTEN
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/PTEN
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: PI3K/PTEN
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: FOXO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: PI3K/PTEN
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/PTEN
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K/PTEN
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K/PTEN
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3411810__F6
redirect_from: /figures/PMC3411810__F6
figtype: Figure
---
